ATP-sensitive inward rectifier potassium channel 1 (ROMK) (ROMK)

The ATP-sensitive inward rectifier potassium channel 1 (ROMK), encoded by the KCNJ1 gene, is a critical ion channel located in the apical membrane of the nephron, specifically in the thick ascending limb (TAL) and the cortical collecting duct (CCD). In the TAL, ROMK facilitates the recycling of potassium ions back into the tubular lumen, a process essential for the continued operation of the NKCC2 cotransporter and the reabsorption of sodium chloride. In the CCD, it serves as the primary pathway for potassium secretion into the urine. Due to its central role in renal electrolyte handling, ROMK is a major therapeutic target for the treatment of hypertension and heart failure; ROMK inhibitors act as novel diuretics that promote natriuresis while potentially minimizing the risk of hypokalemia. Mutations in the KCNJ1 gene are responsible for Bartter syndrome type 1, a condition characterized by severe salt wasting and metabolic alkalosis. Additionally, ROMK has been identified as a molecular component of the mitochondrial ATP-sensitive potassium channel (mitoKATP), where it may play a role in protecting tissues from ischemic damage. The term "Kidney channel" is often used descriptively for ROMK in pharmacological literature, although it is a non-specific term that can also refer to other renal-specific channels such as the chloride channel Ka (CLC-Ka) or energy pathways in traditional medicine.

Other names

Renal outer medullary potassium channelKir1.1KCNJ1Renal outer medullary K+ channelPotassium channel, inwardly rectifying subfamily J member 1Kidney channel

Inhibition of ROMK reduces potassium recycling in the thick ascending limb of Henle's loop, which decreases the driving force for salt reabsorption via the NKCC2 transporter, and also blocks potassium secretion in the cortical collecting duct, resulting in natriuresis and diuresis.